Literature DB >> 23334184

Immobile survival of motoneuron (SMN) protein stored in Cajal bodies can be mobilized by protein interactions.

Benjamin Förthmann1, Hella Brinkmann, Andreas Ratzka, Michal K Stachowiak, Claudia Grothe, Peter Claus.   

Abstract

Reduced levels of survival of motoneuron (SMN) protein lead to spinal muscular atrophy, but it is still unknown how SMN protects motoneurons in the spinal cord against degeneration. In the nucleus, SMN is associated with two types of nuclear bodies denoted as gems and Cajal bodies (CBs). The 23 kDa isoform of fibroblast growth factor-2 (FGF-2(23)) is a nuclear protein that binds to SMN and destabilizes the SMN-Gemin2 complex. In the present study, we show that FGF-2(23) depletes SMN from CBs without affecting their general structure. FRAP analysis of SMN-EGFP in CBs demonstrated that the majority of SMN in CBs remained mobile and allowed quantification of fast, slow and immobile nuclear SMN populations. The potential for SMN release was confirmed by in vivo photoconversion of SMN-Dendra2, indicating that CBs concentrate immobile SMN that could have a specialized function in CBs. FGF-2(23) accelerated SMN release from CBs, accompanied by a conversion of immobile SMN into a mobile population. Furthermore, FGF-2(23) caused snRNP accumulation in CBs. We propose a model in which Cajal bodies store immobile SMN that can be mobilized by its nuclear interaction partner FGF-2(23), leading to U4 snRNP accumulation in CBs, indicating a role for immobile SMN in tri-snRNP assembly.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23334184     DOI: 10.1007/s00018-012-1242-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  62 in total

1.  Coilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy protein.

Authors:  M D Hebert; P W Szymczyk; K B Shpargel; A G Matera
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

2.  Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.

Authors:  P E McAndrew; D W Parsons; L R Simard; C Rochette; P N Ray; J R Mendell; T W Prior; A H Burghes
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

Review 3.  Cajal bodies: a long history of discovery.

Authors:  Mario Cioce; Angus I Lamond
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

4.  Essential role for the tudor domain of SMN in spliceosomal U snRNP assembly: implications for spinal muscular atrophy.

Authors:  D Bühler; V Raker; R Lührmann; U Fischer
Journal:  Hum Mol Genet       Date:  1999-12       Impact factor: 6.150

5.  A novel nuclear structure containing the survival of motor neurons protein.

Authors:  Q Liu; G Dreyfuss
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

6.  The product of the survival of motor neuron (SMN) gene is a human telomerase-associated protein.

Authors:  François Bachand; François-Michel Boisvert; Jocelyn Côté; Stéphane Richard; Chantal Autexier
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

Review 7.  Integrative nuclear FGFR1 signaling (INFS) as a part of a universal "feed-forward-and-gate" signaling module that controls cell growth and differentiation.

Authors:  Michal K Stachowiak; Xiaohong Fang; Jason M Myers; Star M Dunham; Ronald Berezney; Pamela A Maher; Ewa K Stachowiak
Journal:  J Cell Biochem       Date:  2003-11-01       Impact factor: 4.429

8.  Targeted disruption of the FGF-2 gene affects the response to peripheral nerve injury.

Authors:  Julia Jungnickel; Peter Claus; Kathleen Gransalke; Marco Timmer; Claudia Grothe
Journal:  Mol Cell Neurosci       Date:  2004-03       Impact factor: 4.314

9.  Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C.

Authors:  Hu Peng; Jason Myers; Xiaohong Fang; Ewa K Stachowiak; Pamela A Maher; Gabriel G Martins; Gabriela Popescu; Ronald Berezney; Michal K Stachowiak
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

10.  In vivo kinetics of Cajal body components.

Authors:  Miroslav Dundr; Michael D Hebert; Tatiana S Karpova; David Stanek; Hongzi Xu; Karl B Shpargel; U Thomas Meier; Karla M Neugebauer; A Gregory Matera; Tom Misteli
Journal:  J Cell Biol       Date:  2004-03-15       Impact factor: 10.539

View more
  5 in total

Review 1.  A nuclear odyssey: fibroblast growth factor-2 (FGF-2) as a regulator of nuclear homeostasis in the nervous system.

Authors:  Benjamin Förthmann; Claudia Grothe; Peter Claus
Journal:  Cell Mol Life Sci       Date:  2015-01-01       Impact factor: 9.261

Review 2.  Signals controlling Cajal body assembly and function.

Authors:  Michael D Hebert
Journal:  Int J Biochem Cell Biol       Date:  2013-04-10       Impact factor: 5.085

3.  Regulation of neuronal differentiation by proteins associated with nuclear bodies.

Authors:  Benjamin Förthmann; Jeroen van Bergeijk; Yu-Wei Lee; Verena Lübben; Yvonne Schill; Hella Brinkmann; Andreas Ratzka; Michal K Stachowiak; Michael Hebert; Claudia Grothe; Peter Claus
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

4.  NUFIP and the HSP90/R2TP chaperone bind the SMN complex and facilitate assembly of U4-specific proteins.

Authors:  Jonathan Bizarro; Maxime Dodré; Alexandra Huttin; Bruno Charpentier; Florence Schlotter; Christiane Branlant; Céline Verheggen; Séverine Massenet; Edouard Bertrand
Journal:  Nucleic Acids Res       Date:  2015-08-14       Impact factor: 16.971

5.  A Single Amino Acid Residue Regulates PTEN-Binding and Stability of the Spinal Muscular Atrophy Protein SMN.

Authors:  Sebastian Rademacher; Nora T Detering; Tobias Schüning; Robert Lindner; Pamela Santonicola; Inga-Maria Wefel; Janina Dehus; Lisa M Walter; Hella Brinkmann; Agathe Niewienda; Katharina Janek; Miguel A Varela; Melissa Bowerman; Elia Di Schiavi; Peter Claus
Journal:  Cells       Date:  2020-11-03       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.